Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2003-11-26
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 366
- Registration Number
- NCT00003387
- Locations
- 🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
🇺🇸University of California San Diego Cancer Center, La Jolla, California, United States
Paclitaxel in Treating Women With Recurrent Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2003-11-25
- Last Posted Date
- 2016-07-19
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 32
- Registration Number
- NCT00003130
- Locations
- 🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
- Conditions
- Extragonadal Germ Cell TumorTesticular Germ Cell Tumor
- Interventions
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1
- Registration Number
- NCT00072215
- Locations
- 🇺🇸
Broward General Medical Center, Fort Lauderdale, Florida, United States
🇺🇸Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, United States
🇺🇸Palm Beach Cancer Institute - West Palm Beach, West Palm Beach, Florida, United States
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
- Conditions
- Kidney Cancer
- Interventions
- Biological: bevacizumabBiological: recombinant interferon alfa
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 732
- Registration Number
- NCT00072046
- Locations
- 🇺🇸
Doctors Hospital at Ohio Health, Columbus, Ohio, United States
🇺🇸Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Rebecca and John Moores UCSD Cancer Center, San Diego, California, United States
Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
- Conditions
- LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
- Interventions
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 155
- Registration Number
- NCT00072475
- Locations
- 🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital, Fort Lauderdale, Florida, United States
🇺🇸Galesburg Clinic, PC, Galesburg, Illinois, United States
Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Radiation: radiation therapy
- First Posted Date
- 2003-11-05
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 78
- Registration Number
- NCT00072527
- Locations
- 🇺🇸
McDonough District Hospital, Macomb, Illinois, United States
🇺🇸Hudner Oncology Center at Saint Anne's Hospital, Fall River, Massachusetts, United States
🇺🇸Saint Luke's Hospital, Chesterfield, Missouri, United States
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2003-11-05
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 59
- Registration Number
- NCT00005964
- Locations
- 🇺🇸
Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States
🇺🇸Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
🇺🇸State University of New York - Upstate Medical University, Syracuse, New York, United States
Genetic Study of Patients and Families With a History of Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Genetic: DNA stability analysisGenetic: gene rearrangement analysis
- First Posted Date
- 2003-10-29
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1500
- Registration Number
- NCT00003648
- Locations
- 🇺🇸
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
🇺🇸CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States
🇺🇸Mayo Clinic Cancer Center, Rochester, Minnesota, United States
Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss
- Conditions
- Multiple Myeloma and Plasma Cell NeoplasmLeukemiaLymphoma
- Interventions
- Dietary Supplement: omega-3 fatty acid
- First Posted Date
- 2003-10-22
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 63
- Registration Number
- NCT00003077
- Locations
- 🇺🇸
CCOP - Christiana Care Health Services, Wilmington, Delaware, United States
🇺🇸Holden Comprehensive Cancer Center at The University of Iowa, Iowa City, Iowa, United States
🇺🇸North Shore University Hospital, Manhasset, New York, United States
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
- Conditions
- Lung CancerDrug/Agent Toxicity by Tissue/OrganRadiation Toxicity
- Interventions
- Biological: filgrastimRadiation: radiation therapy
- First Posted Date
- 2003-10-08
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 73
- Registration Number
- NCT00006012
- Locations
- 🇺🇸
Galesburg Cottage Hospital, Galesburg, Illinois, United States
🇺🇸Siouxland Regional Cancer Center, Sioux City, Iowa, United States
🇺🇸St. Elizabeth Regional Medical Center, Lincoln, Nebraska, United States